Recently, there have been rumors that red yeast rice health products can assist in lowering blood lipids, and the main effects are blood circulation and blood stasis, spleen and digestion, lipid reduction and turbidity, etc., which can be widely used for a long time.
In this regard, on April 29, the "Beijing Internet Report" issued an article to refute the rumors. Red yeast rice, also known as red yeast rice, is a medicinal and edible traditional Chinese medicine made from rice fermented under the action of Monascus mold. If the rice used for the production of red yeast rice or the red yeast rice produced is not stored properly, and Aspergillus flavus mildew occurs and deteriorates, the highly toxic substance aflatoxin will be produced, and taking a certain dose can cause liver and kidney damage.
Recently, some consumers died due to taking health products containing red yeast rice ingredients from the Japanese company Kobayashi Pharmaceutical.
Japan's Ministry of Health, Labor and Welfare announced on March 26 that the number of hospital admissions has risen to 106 after ingesting a health supplement containing Kobayashi Pharmaceutical's "red yeast rice" ingredient, NHK reported. Kobayashi Pharmaceutical has called on consumers to stop using the affected products.
Then, on March 27, the company received a notification that two more consumers had died after taking the company's health products containing red yeast rice. As of the evening of March 28, five consumers who took the company's health products had died and 114 were hospitalized.
Akihiro Kobayashi, chairman of Kobayashi Pharmaceutical Co., Ltd., apologized
Subsequently, the relevant departments of the Japanese Ministry of Health, Labor and Welfare and the Wakayama County Government entered the company's factory in Kinokawa City, Wakayama Prefecture to conduct an on-site inspection around the suspected damage to consumers' health caused by Kobayashi Pharmaceutical Company's health products containing red yeast rice raw materials.
According to a survey by a relevant database company, Kobayashi Pharmaceutical provides red yeast rice raw materials to 225 companies, some of which are sold directly, and some are resold after processing, and 33,000 companies may be affected. The foods processed by companies that purchase the raw materials of the red yeast rice in question include natto, bread, lunch boxes, salted fish, pickled vegetables, and fermented foods.
According to Japan's Ministry of Health, Labor and Welfare on April 4, Kobayashi Pharmaceutical reported that as of April 3, the number of hospitalizations related to taking the company's health products containing red yeast rice ingredients increased to 188.
On April 9, the Japanese Society of Nephrology announced the results of Kobayashi Pharmaceutical's "Red Yeast Rice Storm", and most patients had a common condition "Fanconi syndrome", that is, renal tubular dysfunction. These patients have abnormal tubular function and are unable to recover many of the substances that the body needs, but instead excrete them.
Here, the "Beijing Online Report" reminds that if consumers want to buy health care products through overseas cross-border platforms, overseas physical stores or other channels, they must look for the "blue hat" of health food (the sky blue logo for domestic health food, which is in the shape of a hat, commonly known as "blue hat" in the industry).
According to Article 76 of the Food Safety Law of the People's Republic of China, imported health products should be filed with the food and drug supervision and administration department and wear the "blue hat" logo before entering the Chinese market. Therefore, it is necessary to see whether there is a batch number of Guoshijian, and pay attention to whether the product has a trademark, product name, production date, expiration date and other health food standard requirements, etc., and if necessary, you can also check the official website of the State Administration for Market Regulation.
(Comprehensive Beijing Network Release, Xinhua News Agency, CCTV News, China News Network, Overseas Network, etc.)